Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1864 1
1880 1
1947 4
1948 4
1950 3
1951 2
1952 1
1953 1
1954 4
1955 6
1956 7
1957 2
1958 2
1959 1
1960 1
1961 1
1962 2
1963 2
1964 8
1965 5
1966 4
1967 8
1968 6
1969 11
1970 8
1971 4
1972 7
1973 9
1974 7
1975 3
1976 3
1977 13
1978 8
1979 18
1980 7
1981 7
1982 14
1983 17
1984 22
1985 16
1986 24
1987 36
1988 23
1989 33
1990 39
1991 26
1992 37
1993 33
1994 38
1995 25
1996 32
1997 33
1998 34
1999 31
2000 31
2001 40
2002 45
2003 56
2004 61
2005 53
2006 72
2007 70
2008 84
2009 85
2010 65
2011 74
2012 77
2013 89
2014 81
2015 76
2016 89
2017 74
2018 86
2019 88
2020 137
2021 142
2022 158
2023 125
2024 133
2025 113

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,633 results

Results by year

Filters applied: . Clear all
Page 1
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Provan D, et al. Among authors: michel m. Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812. Blood Adv. 2019. PMID: 31770441 Free PMC article.
Evans' Syndrome: From Diagnosis to Treatment.
Audia S, Grienay N, Mounier M, Michel M, Bonnotte B. Audia S, et al. Among authors: michel m. J Clin Med. 2020 Nov 27;9(12):3851. doi: 10.3390/jcm9123851. J Clin Med. 2020. PMID: 33260979 Free PMC article. Review.
TT-seq maps the human transient transcriptome.
Schwalb B, Michel M, Zacher B, Frühauf K, Demel C, Tresch A, Gagneur J, Cramer P. Schwalb B, et al. Among authors: michel m. Science. 2016 Jun 3;352(6290):1225-8. doi: 10.1126/science.aad9841. Science. 2016. PMID: 27257258
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases.
Michaudel C, Danne C, Agus A, Magniez A, Aucouturier A, Spatz M, Lefevre A, Kirchgesner J, Rolhion N, Wang Y, Lavelle A, Galbert C, Da Costa G, Poirier M, Lapière A, Planchais J, Nádvorník P, Illes P, Oeuvray C, Creusot L, Michel ML, Benech N, Bourrier A, Nion-Larmurier I, Landman C, Richard ML, Emond P, Seksik P, Beaugerie L, Arguello RR, Moulin D, Mani S, Dvorák Z, Bermúdez-Humarán LG, Langella P, Sokol H. Michaudel C, et al. Among authors: michel ml. Gut. 2023 Jul;72(7):1296-1307. doi: 10.1136/gutjnl-2022-327337. Epub 2022 Oct 21. Gut. 2023. PMID: 36270778 Free PMC article.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Among authors: michel m. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life.
Cooper N, Kruse A, Kruse C, Watson S, Morgan M, Provan D, Ghanima W, Arnold DM, Tomiyama Y, Santoro C, Michel M, Laborde S, Lovrencic B, Hou M, Bailey T, Taylor-Stokes G, Haenig J, Bussel JB. Cooper N, et al. Among authors: michel m. Am J Hematol. 2021 Feb 1;96(2):199-207. doi: 10.1002/ajh.26036. Epub 2020 Dec 19. Am J Hematol. 2021. PMID: 33107998 Free PMC article.
Project-Based Public-Private Collaborations.
Hein P, Michel MC. Hein P, et al. Among authors: michel mc. Handb Exp Pharmacol. 2024;286:21-31. doi: 10.1007/164_2024_722. Handb Exp Pharmacol. 2024. PMID: 39120768 Review.
A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study).
Michel M, Terriou L, Roudot-Thoraval F, Hamidou M, Ebbo M, Le Guenno G, Galicier L, Audia S, Royer B, Morin AS, Marie Michot J, Jaccard A, Frenzel L, Khellaf M, Godeau B. Michel M, et al. Am J Hematol. 2017 Jan;92(1):23-27. doi: 10.1002/ajh.24570. Epub 2016 Nov 10. Am J Hematol. 2017. PMID: 27696475 Free article. Clinical Trial.
Editorial Comment.
Michel MC. Michel MC. J Urol. 2020 Aug;204(2):324. doi: 10.1097/JU.0000000000000807.02. Epub 2020 May 21. J Urol. 2020. PMID: 32436758 No abstract available.
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers.
Hehle V, Beretta M, Bourgine M, Ait-Goughoulte M, Planchais C, Morisse S, Vesin B, Lorin V, Hieu T, Stauffer A, Fiquet O, Dimitrov JD, Michel ML, Ungeheuer MN, Sureau C, Pol S, Di Santo JP, Strick-Marchand H, Pelletier N, Mouquet H. Hehle V, et al. Among authors: michel ml. J Exp Med. 2020 Oct 5;217(10):e20200840. doi: 10.1084/jem.20200840. J Exp Med. 2020. PMID: 32579155 Free PMC article.
2,633 results